Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in certain receptors can cause diseases and offer new treatment options.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Spironolactone might lower the chance of getting rosacea.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Early treatment is important for better hair regrowth in elderly women with hair loss.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The free androgen index varies among women with different types of PCOS.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.